Peptide Synthesis Explained for Non-Chemists

Peptides are central tools in modern laboratory research, used as biochemical probes, assay controls, receptor ligands, enzyme substrates, antigens, and building blocks for more complex constructs. Yet the phrase “peptide synthesis” can sound highly technical to researchers who do not routinely work in organic chemistry.

This article provides peptide synthesis explained in plain scientific language: how research peptides are typically made, what “purity” and “identity” checks mean, and why some sequences are harder than others. The focus is on laboratory research supply and characterisation, not clinical use.

If you are new to the topic, it can help to start with terminology: What are peptides? (basic definitions for researchers).

What peptide synthesis aims to achieve

At a high level, peptide synthesis is the controlled assembly of amino acids into a defined sequence connected by peptide bonds. In research supply, the goal is typically to produce a peptide that:

Matches a specified amino-acid sequence (and any stated modifications)
Has a known, documented identity (commonly via mass spectrometry)
Meets an agreed purity level (commonly estimated by analytical HPLC)
Is delivered in a stable form suitable for research handling (often lyophilised)

Because peptide synthesis is stepwise chemistry, each added amino acid is an opportunity for small inefficiencies. The practical art of synthesis is therefore not only “building the chain,” but also preventing side reactions and verifying the final material with appropriate analytics.

The most common approach: solid-phase peptide synthesis (SPPS)

Most custom and catalogue research peptides are made using solid-phase peptide synthesis (SPPS). SPPS means the growing peptide remains attached to an insoluble solid support (a resin bead) while amino acids are added one at a time. This design is popular because after each chemical step, excess reagents and by-products can be washed away while the peptide stays bound to the resin.

SPPS is often described as “assembly-line chemistry” for peptides: the same cycle repeats for each residue, with careful control over timing, reagent quality, and reaction conditions.

Key building blocks and reagents (conceptually)

A resin: the solid support that anchors the peptide during chain assembly.
Protected amino acids: amino acids whose reactive groups are temporarily “masked” to enforce correct bond formation.
Activating/coupling reagents: chemicals that promote peptide bond formation between the incoming amino acid and the growing chain.
Deprotection reagents: chemicals that remove temporary protecting groups at the right time so the next bond can form.

Different laboratories may select different resin types, coupling reagents, and protection strategies depending on sequence difficulty, desired C-terminus, or required modifications. The core logic remains the same: repeatable cycles that extend the chain in a defined order.

Why protecting groups are essential

Amino acids contain multiple reactive sites. Without control, these sites could react in unwanted ways, leading to branching or incorrect linkages. Protecting groups are temporary chemical “caps” placed on certain reactive groups so that only the intended peptide bond forms during each coupling step.

In a typical SPPS strategy, one amino group is alternately protected and deprotected in cycles, while side-chain reactive groups remain protected until the end. This approach:

Reduces side reactions during stepwise assembly
Improves the probability of producing the intended full-length sequence
Allows sensitive side chains (for example, those that might be easily modified) to remain “quiet” until final cleavage

For a practical overview of changes that can be introduced intentionally at the ends or side chains (for example, caps and labels), see Common peptide modifications (amidation, acetylation, labels) explained.

SPPS step-by-step (high-level workflow)

Although synthesis protocols contain many details, the conceptual workflow is straightforward. Below is a non-technical map of what happens in many SPPS processes.

1) Resin loading (starting point)

The synthesis begins by attaching the first amino acid (or an appropriate linker) to the resin. This defines the peptide’s C-terminal end chemistry and provides a stable anchor for subsequent cycles. The choice of resin and linker helps determine whether the final peptide will have a free acid, amide, or other C-terminal functionality.

2) Deprotection (making the chain ready to grow)

Before adding the next amino acid, a temporary protecting group on the growing chain is removed. This exposes a reactive amine so it can form the next peptide bond.

3) Coupling (adding one amino acid)

A protected amino acid is activated and reacts with the exposed amine on the resin-bound chain, forming a new peptide bond. Ideally, each coupling step goes to completion. In practice, coupling efficiency can vary depending on the residue being added and the sequence context.

4) Washing (removing excess reagents)

After each step, the resin is washed so that unreacted amino acids, activators, and soluble by-products are removed. This is a central advantage of SPPS: the product stays on the resin, enabling rapid cleanup between cycles.

5) Repeating the cycle

Steps 2–4 repeat until the full sequence is assembled. As the peptide grows longer, the risk of incomplete couplings or aggregation can increase, which is one reason longer sequences may require additional optimisation or alternative strategies.

6) Final deprotection and cleavage (releasing the peptide)

Once assembly is complete, the peptide is cleaved off the resin and side-chain protecting groups are removed. This is a key transition: the peptide becomes a free, soluble material (often in a complex mixture) rather than a resin-bound chain.

What “crude peptide” means (and why purification matters)

The direct product after cleavage is commonly called crude peptide. Crude material often contains:

The target peptide sequence
Truncated sequences (from incomplete couplings)
Deletion variants (missing one or more residues)
Side products (from unwanted reactions during synthesis or cleavage)
Salts and small-molecule remnants from processing

For many laboratory applications, purification is used to enrich the target peptide and reduce by-products. The most common approach is preparative reversed-phase HPLC, where components are separated based on their interaction with the chromatography system under a defined solvent gradient.

It is important to interpret “purity” in the context of a stated method: purity is typically estimated by analytical HPLC under specific conditions, which may separate some impurities well and others less well. A single number does not always capture every possible impurity type or behaviour in a different analytical system.

Quality control: how identity and purity are checked

Research peptides are commonly supplied with a certificate of analysis (COA) or similar documentation summarising characterisation. While formats vary, two widely used measurements are analytical HPLC and mass spectrometry.

A deeper discussion of how these metrics are generated and interpreted is available here: Understanding peptide purity: HPLC, MS and what a COA shows.

Analytical HPLC (purity estimation)

Analytical HPLC separates components in the sample and produces a chromatogram with peaks. Purity is often estimated by integrating the main peak area as a fraction of total detected peak area under a specified method. This provides a practical comparative measure for batch release and method consistency.

Key nuance for non-chemists: HPLC purity depends on the method and detector settings. Two peptides (or two impurities) may absorb differently, co-elute, or separate differently under another gradient. For this reason, HPLC purity is best understood as an operational measurement tied to the stated conditions.

Mass spectrometry (identity confirmation)

Mass spectrometry (MS) checks whether the measured molecular mass matches the expected mass of the intended sequence (including any modifications). When the observed mass aligns with the theoretical mass, it strongly supports correct identity.

MS is highly informative, but it is not always a complete structural proof by itself. For example, some isomers can share the same mass. Where necessary, additional analytical approaches (such as MS/MS sequencing, amino-acid analysis, or complementary chromatography) may be used depending on research requirements.

Why some sequences are more difficult to synthesise

Not all peptide sequences behave the same way on resin or during purification. Certain properties can reduce coupling efficiency or increase the formation of by-products.

Length and stepwise yield

Because SPPS adds residues one at a time, small inefficiencies can accumulate. Even if each coupling step is “mostly complete,” the fraction of full-length product can decline with increasing length. This is one reason that longer peptides are often more challenging to produce at high purity, and why some projects consider fragment-based assembly approaches.

Hydrophobicity and aggregation

Hydrophobic sequences can interact strongly with themselves or with the resin environment, sometimes forming aggregated structures that physically hinder reagents from reaching reactive sites. Aggregation can lead to incomplete couplings and a higher proportion of truncated or modified side products.

Problematic motifs and residues

Some sequence motifs are associated with increased side reactions or steric hindrance. In practical synthesis planning, chemists may adjust coupling times, use double couplings, alter solvents, or use backbone-protecting strategies to improve outcomes. These changes are part of process optimisation rather than a guarantee of success for every sequence.

Modifications and non-standard building blocks

Adding labels, unusual amino acids, cyclisation elements, or other modifications may introduce extra steps, specialised reagents, or additional purification challenges. Even when the chemistry is well established, each additional transformation can affect overall yield and impurity profile. For a non-technical overview of common options, see Common peptide modifications (amidation, acetylation, labels) explained.

Peptide vs polypeptide: what’s the difference?

Both peptides and polypeptides are chains of amino acids linked by peptide bonds. In everyday laboratory language, “peptide” often refers to shorter sequences, while “polypeptide” may imply a longer chain. There is no universal cutoff, and different fields use different conventions. From a chemistry standpoint, the same bond-forming logic applies, but longer chains tend to amplify synthesis and purification challenges.

Can any peptide be made by chemical synthesis?

Many research peptides are feasible by SPPS, but “any peptide” is not always practical. Feasibility depends on:

Length (longer sequences are generally harder)
Sequence properties (hydrophobicity, aggregation tendency, challenging motifs)
Required purity (higher purity typically requires more stringent purification)
Modifications (labels, cyclisation, unusual residues)
Intended analytical confirmation (some projects require deeper characterisation)

For very long targets or protein-like domains, labs may use fragment-based chemical approaches (making shorter fragments then joining them) or recombinant expression, sometimes combined with chemical modification afterward. The “best” approach is determined by the research goal and the constraints of chemistry, analytics, and timeline.

After synthesis: stability, storage, and handling in the lab

Once a peptide is produced and characterised, preserving its integrity becomes a practical laboratory concern. Many research peptides are supplied as lyophilised solids to improve stability during shipping and storage. However, peptides can be sensitive to moisture uptake, repeated freeze-thaw cycles, oxidation, and contamination introduced during handling.

For laboratory-focused guidance on good practice (without implying any clinical use), the following resources may be helpful:

As with any research reagent, documenting lot numbers, storage conditions, and preparation steps can improve reproducibility across experiments and between research groups.

FAQ

What is solid-phase peptide synthesis (SPPS)?

SPPS is a chemical method where a peptide is built step-by-step while attached to an insoluble resin bead. After each amino acid addition, excess reagents can be washed away, making the process efficient and scalable for many research peptides.

Why do peptides need protecting groups during synthesis?

Amino acids have multiple reactive sites. Protecting groups temporarily “mask” certain sites so the correct bond forms at each step, reducing side reactions and improving the chance of obtaining the intended sequence.

What does ‘crude peptide’ mean?

Crude peptide is the material obtained right after cleavage from the resin. It typically contains the target peptide plus by-products such as truncated sequences and side products, so purification is often required.

How is peptide purity measured?

Purity is commonly estimated using analytical HPLC by integrating the main peak relative to other peaks under a defined method. It’s a useful comparative metric, but it depends on the specific analytical conditions and doesn’t alone describe every possible impurity.

How do labs confirm a peptide’s identity?

Identity is typically confirmed with mass spectrometry (MS), which checks whether the measured molecular mass matches the expected mass for the sequence (and any stated modifications).

Why are some peptide sequences more difficult to synthesise than others?

Longer peptides and sequences that are highly hydrophobic or prone to aggregation can reduce coupling efficiency and increase by-products. Certain modifications or unusual residues can also add extra steps and complexity.

What’s the difference between a peptide and a polypeptide?

Both are chains of amino acids. In practice, ‘peptide’ often refers to shorter chains, while ‘polypeptide’ may imply a longer chain. The exact cutoff varies by field, but the underlying chemistry is the same.

Can any peptide be made by chemical synthesis?

Many can, but feasibility depends on length, sequence properties, and required modifications/purity. For very long sequences, labs may use fragment approaches or recombinant expression instead of (or in addition to) chemical synthesis.

Summary: peptide synthesis explained in one paragraph

In research supply, peptide synthesis most often uses SPPS, where a peptide is assembled one residue at a time on a resin with the help of protecting groups that control reactivity. After chain assembly, the peptide is cleaved, yielding crude material that typically requires purification (often by HPLC). Quality control then checks identity (commonly by MS) and estimates purity (commonly by analytical HPLC), with practical limits set by sequence length, aggregation tendencies, and the complexity of any modifications. Understanding these steps helps non-chemists interpret specifications and COAs and plan experiments with realistic expectations about peptide behaviour and variability.